29
Views
0
CrossRef citations to date
0
Altmetric
Patenting Trends

Patenting Trends in the Pharmaceutical Field of Mexican Universities

ORCID Icon, ORCID Icon & ORCID Icon
Pages 37-50 | Received 26 Oct 2022, Accepted 14 Dec 2022, Published online: 01 Feb 2023

References

  • Hall BH . Patents, innovation, and development. Inter. Rev. Appl. Econ. doi: 10.1080/02692171.2021.2022295 (2022) ( Epub ahead of print).
  • Katzman RS , AzzizR. Technology transfer and commercialization as a source for new revenue generation for higher education institutions and for local economies. In: International Experience in Developing the Financial Resources of Universities.Springer, Cham, 89–111 (2021).
  • Daniel AD , AlvesL. University-industry technology transfer: the commercialization of university's patents. Knowl. Manag. Res. Pract.18(3), 276–296 (2020).
  • Caviggioli F , DeMarco A , MontobbioFet al. The licensing and selling of inventions by US universities. Technol. Forecast Soc. Change159, 120189 (2020).
  • Hockaday T . University Technology Transfer: What it is and how to Do it.JHU Press, MD, USA, 65–101 (2020).
  • Holgersson M , AaboenL. A literature review of intellectual property management in technology transfer offices: from appropriation to utilization. Technol. Soc.59, 101132 (2019).
  • Arenas JJ , GonzálezD. Technology transfer models and elements in the university-industry collaboration. Adm Sci.8(2), 19 (2019).
  • Min KB , LeeC , KimYC. The impact of the timing of patent allowance on technology licensing performance: evidence from university invention commercialization. R&D Management.52(4), 633–649 (2022).
  • Fai FM , de BeerC , SchutteCS. Towards a novel technology transfer office typology and recommendations for developing countries. Ind. High. Educ.32(4), 213–225 (2018).
  • Soares AM , KovaleskiJL , GaiaS , ChiroliDMDG. Building sustainable development through technology transfer offices: an approach based on levels of maturity. Sustainability12(5), 1795 (2020).
  • Sargent J , MatthewsL. Latin American universities and technology commercialization. Lat. Am. Bus. Rev.15(2), 167–190 (2014).
  • Ramirez-Hernandez LF , Isaza-CastroJG. When size matters: trends in innovation and patents in latin american universities. J. Technol. Manag. Innov.14(3), 44–56 (2019).
  • Méndez-Morales A , Ochoa-UrregoR , RandhirT O. Measuring the quality of patents among Latin-American universities. Stud. High. Educ.47(11), 2174–2189 (2022).
  • Peérez CD , LópezMS. Patentes de universidades mexicanas. Reencuentro. Análisis de problemas universitarios.32(80), 185–205 (2020).
  • Universidad Nacional Autonoma de Mexico . MX246172 (2003).
  • Segura-Pacheco B , Trejo-BecerrilC , Perez-CardenasEet al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin. Cancer Res.9(5), 1596–1603 (2003).
  • Universidad Nacional Autonoma de Mexico . MX2007010896 (2009).
  • Velasco-Loyden G , Pérez-MartínezL , Vidrio-GómezSet al. Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats. Tumour Biol.39(2), 1010428317691190 (2017).
  • Universidad Nacional Autonoma de Mexico . MX2008006358 (2009).
  • Chavez-Blanco A , Perez-PlasenciaC , Perez-CardenasEet al. Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines. Cancer Cell Int.6(1), 1–9 (2006).
  • Mora-García M de L , Duenas-GonzálezA , Hernández-MontesJet al. Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid. J. Transl. Med.4(1), 1–14 (2006).
  • De la Cruz-Hernández E , Perez-PlasenciaC , Pérez-CardenasEet al. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma. Oncol. Rep.25(2), 399–407 (2011).
  • Cervera E , CandelariaM , López-NavarroOet al. Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia. Clin. Lymphoma Myeloma Leuk.12(3), 207–212 (2012).
  • Espinoza-Zamora JR , Labardini-MéndezJ , Sosa-EspinozaAet al. Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. Expert Opin. Investig. Drugs26(4), 481–487 (2017).
  • Universidad Nacional Autonoma de Mexico . MX2008008681 (2010).
  • Angel-Corona R , Corona-OrtegaT , del Río-OrtizIet al. Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice. J. Drug Target.19(2), 79–85 (2011).
  • Universidad Autonoma de Nuevo Leon . MX2008016104 (2010).
  • Zamora-Avila DE , Zapata-BenavidesP , Franco-MolinaMAet al. WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther.16(12), 892–899 (2009).
  • Zapata-Benavides P , Thompson-ArmendarizFG , Arellano-RodríguezMet al. shRNA-WT1 potentiates anticancer effects of gemcitabine and cisplatin against B16F10 lung metastases in vitro and in vivo. In Vivo33(3), 777–785 (2019).
  • Universidad Nacional Autonoma de Mexico . MX2012002675 (2013).
  • Aguiñiga-Sánchez I , Soto-HernándezM , Cadena-IñiguezJet al. Fruit extract from a Sechium edule hybrid induces apoptosis in leukaemic cell lines but not in normal cells. Nutr. Cancer67(2), 250–257 (2015).
  • Universidad Nacional Autonoma de Mexico . MX2012011264 (2014).
  • Ledesma-Martínez E , Pérez-CorderoC , Córdova-GalavizYet al. Casein induces the proliferation of bone marrow mononuclear cells, apoptosis of WEHI-3 leukaemic cells and increased survival in a leukaemia mouse model. Oncol. Lett.4(3), 461–466 (2012).
  • Córdova-Galaviz Y , Ledesma-MartínezE , Aguíñiga-SánchezIet al. Sodium caseinate induces increased survival in leukaemic mouse J774 model. In Vivo28(5), 819–825 (2014).
  • Universidad Autonoma Metropolitana . MX2012012415 (2014).
  • Camacho-Camacho C , Rojas-OviedoI , Garza-OrtizAet al. Synthesis, structural characterization and in vitro cytotoxic activity of novel polymeric triorganotin (IV) complexes of urocanic acid. Appl. Organomet. Chem.27(1), 45–51 (2013).
  • Universidad Nacional Autonoma de Mexico . MX2012013225 (2014).
  • Universidad Autonoma de Nuevo Leon . MX2013002158 (2014).
  • Gomez-Flores R , Quintanilla-LiceaR , Verde-StarMJ. Long-chain alkanes and ent-labdane-type diterpenes from Gymnosperma glutinosum with cytotoxic activity against the murine lymphoma L5178Y-R. Phytother. Res.26(11), 1632–1636 (2012).
  • Universidad Nacional Autonoma de Mexico . MX2013006632 (2014).
  • Instituto Politecnico Nacional . MX2013002766 (2014).
  • Prestegui-Martel B , Bermúdez-LugoJA , Chávez-BlancoA , Dueñas-GonzálezAet al. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells. J Enzyme Inhib. Med. Chem.31(sup. 3), 140–149 (2016).
  • Contis-Montes de Oca A , Rodarte-ValleE , Rosales-HernándezMC , Abarca-RojanoEet al. N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells. Oncotarget.9(70), 33368–33381 (2018).
  • Sixto-López Y , Rosales-HernándezMC , Contis-Montesde Oca Aet al. N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells. Int J Mol Sci.21(16), 5873 (2020).
  • Instituto Politecnico Nacional . MX2014001582 (2015).
  • Frías González SE , AngelesAnguiano E , MendozaHerrera Aet al. Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(II) complex against human cervical cancer. Toxicology314(1), 155–165 (2013).
  • Universidad Nacional Autonoma de Mexico . MX2014003941 (2015).
  • Macías-Pérez JR , Beltrán-RamírezO , Vásquez-GarzónVRet al. The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model. Anticancer Drugs24(4), 394–405 (2013).
  • Universidad Autonoma de Nuevo Leon . MX2014011793 (2015).
  • Hernández-Martínez H , Gómez-FloresR , Tamez-GuerraPet al. Antitumor activity of Pachycereus marginatus (DC.) Britton & Rose extracts against murine lymphoma L5178Y-R and skin melanoma B16F10 cells. J. Med. Plant. Res.10(36), 635–639 (2016).
  • Gomez-Flores R , Quintanilla-LiceaR , Hernández-MartínezHCet al. Survival of lymphoma-bearing mice by Pachycereus marginatus cactus extracts and elucidation of bioactive compounds. Nat. Prod. Commun.14(5), 1934578X19845814 (2019).
  • Instituto Politecnico Nacional . MX2014015323 (2016).
  • Arias-González I , García-CarrancáAM , Cornejo-GarridoJ , Ordaz-PichardoC. Cytotoxic effect of Kalanchoe flammea and induction of intrinsic mitochondrial apoptotic signaling in prostate cancer cells. J. Ethnopharmacol.222, 133–147 (2018).
  • Universidad Nacional Autonoma de Mexico . MX2015016921 (2016).
  • Bautista E , Fragoso-SerranoM , ToscanoRAet al. Teotihuacanin, a diterpene with an unusual spiro-10/6 system from Salvia amarissima with potent modulatory activity of multidrug resistance in cancer cells. Or.g Lett.17(13), 3280–3282 (2015).
  • Universidad Autonoma de Nuevo Leon . MX2014016064 (2016).
  • Universidad Autonoma de Nuevo Leon . MX2014016072 (2016).
  • Universidad Nacional Autonoma de Mexico . MX2016002862 (2016).
  • Universidad Autonoma Metropolitana . MX2015008846 (2017).
  • Rojas-Oviedo I , Camacho-CamachoC , Sánchez-SánchezLet al. Synthesis and characterization of tributyltin derivatives from 4-oxo-4-(arylamino) butanoic acids and their in vitro biological activity against cervical cancer cell lines. Appl. Organomet. Chem.28(12), 884–891 (2014).
  • Universidad Autonoma de Nuevo León . MX2015011686 (2017).
  • Universidad Autonoma de Nuevo Leon . MX2015014863 (2107).
  • Arredondo-Espinoza EU , López-CortinaST , Ramírez-CabreraMAet al. Synthesis and photodynamic activity of unsymmetrical A3B tetraarylporphyrins functionalized with l-glutamate and their Zn(II) and Cu(II) metal complex derivatives. Biomed. Pharmacother.82, 327–336 (2016).
  • Universidad Nacional Autonoma de Mexico . MX2016006460 (2017).
  • Torres-García D , Pérez-TorresA , ManoutcharianKet al. GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model. Vaccine35(42), 5653–5661 (2017).
  • Rodríguez-Rodríguez N , Madera-SalcedoIK , Bugarin-EstradaEet al. The helminth-derived peptide GK-1 induces an antitumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway. Clin. Immunol.212, 108240 (2020).
  • Benemerita Universidad Autonoma de Puebla . MX2016013947 (2018).
  • Sánchez-Sánchez L , Hernández-LinaresMG , EscobarMLet al. Antiproliferative, cytotoxic, and apoptotic activity of steroidal oximes in cervicouterine cell lines. Molecules21(11), 1533 (2016).
  • Benemerita Universidad Autonoma de Puebla . MX2016013945 (2018).
  • Instituto Politecnico Nacional . MX2017002995 (2018).
  • Rodríguez-Fonseca RA , Sixto-LópezY , Fragoso-VázquezMJet al. Design, synthesis and biological evaluation of a phenyl butyric acid derivative, N-(4-chlorophenyl)-4-phenylbutanamide: a HDAC6 inhibitor with anti-proliferative activity on cervix cancer and leukemia cells. Anticancer Agents Med. Chem.17(10), 1441–1454 (2017).
  • Universidad Autonoma de Nuevo Leon . MX2017013502 (2019).
  • Hernandez-Delgadillo R , García-CuéllarCM , Sánchez-PérezYet al. In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells. Int. J. Nanomedicine13, 6089–6097 (2018).
  • Cabral-Romero C , Solís-SotoJM , Sánchez-PérezYet al. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells. Anticancer Drugs31(3), 251–259 (2020).
  • García-Cuellar CM , Cabral-RomeroC , Hernández-DelgadilloRet al. Bismuth lipophilic nanoparticles (BisBAL NP) inhibit the growth of tumor cells in a mouse melanoma model. Anticancer Agents Med. Chem.22(14), 2548–2557 (2022).
  • Universidad Autonoma Metropolitana . MXPA02012315 (2004).
  • Benemerita Universidad Autonoma de Puebla . MX2011013386 (2013).
  • Benemerita Universidad Autonoma de Puebla . MX2015003461 (2016).
  • Treviño S , Velázquez-VázquezD , Sánchez-LaraEet al. Metforminium decavanadate as a potential metallopharmaceutical drug for the treatment of diabetes mellitus. Oxid. Med. Cell. Longev.6058705 (2016).
  • Treviño S , González-VergaraE. Metformin-decavanadate treatment ameliorates hyperglycemia and redox balance of the liver and muscle in a rat model of alloxan-induced diabetes. New J. Chem.43(45), 17850–17862 (2019).
  • Diaz A , Muñoz-ArenasG , VenegasBet al. Metforminium decavanadate (MetfDeca) treatment ameliorates hippocampal neurodegeneration and recognition memory in a metabolic syndrome model. Neurochem. Res.46(5), 1151–1165 (2021).
  • Benemerita Universidad Autonoma de Puebla . MX2012006361 (2013).
  • Benemerita Universidad Autonoma de Puebla . MX2015014275 (2016).
  • Instituto Politecnico Nacional . MX2015016506 (2017).
  • Domínguez-Mendoza EA , Cornejo-GarridoJ , Burgueño-TapiaEet al. Antidiabetic effect, antioxidant activity, and toxicity of 3′,4′-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats. Bioorg. Med. Chem. Lett.26(16), 4086–4091 (2016).
  • Universidad Autonoma de Nuevo Leon . MX2017007661 (2019).
  • Universidad Nacional Autonoma de Mexico . MXPA98005424A (2000).
  • Gevorkian G , ManoutcharianK , LarraldeCet al. Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis. Immunol. Lett.49(3), 185–189 (1996).
  • Toledo A , LarraldeC , FragosoGet al. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infect. Immun.67(5), 2522–2530 (1999).
  • García G , SciuttoE , FragosoGet al. Inhibitory role of antibodies in the development of Taenia solium and Taenia crassiceps toward reproductive and pathogenic stages. J. Parasitol.87(3), 582586 (2001).
  • Hernández M , Cabrera-PonceJL , FragosoGet al. A new highly effective anticysticercosis vaccine expressed in transgenic papaya. Vaccine25(21), 4252–4260 (2007).
  • Instituto Politecnico Nacional . MX2017001766 (2017).
  • Lara-Ramirez EE , López-CedilloJC , Nogueda-TorresBet al. An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method. Eur. J. Med. Chem.132, 249–261 (2017).
  • Instituto Politecnico Nacional . MX2016017197 (2018).
  • Instituto Politecnico Nacional . MX2016017177 (2018).
  • Instituto Politecnico Nacional . MX2016016018 (2018).
  • Instituto Politecnico Nacional . MX2016017183 (2018).
  • Instituto Politecnico Nacional . MX2016017186 (2018).
  • Palos I , Lara-RamirezEE , Lopez-CedilloJCet al. Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: virtual screening. In Vitro and In Vivo Studies. Molecules.22(6), 1015 (2017).
  • Instituto Politecnico Nacional . MX2016017182 (2018).
  • Universidad Autonoma de Nuevo Leon . MX2008016111 (2010).
  • Trujillo-Murillo K , Rincón-SánchezAR , Martínez-RodríguezHet al. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. Hepatology47(5), 1462–1472 (2008).
  • Rivas-Estilla AM , Bryan-MarrugoOL , Trujillo-MurilloKet al. Cu/Zn superoxide dismutase (SOD1) induction is implicated in the antioxidative and antiviral activity of acetylsalicylic acid in HCV-expressing cells. Am. J. Physiol. Gastrointest. Liver Physiol.302(11), G1264–1273 (2012).
  • Ríos-Ibarra CP , Lozano-SepulvedaS , Muñoz-EspinosaLet al. Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells. Arch. Virol.159(12), 3321–3328 (2014).
  • Universidad Autonoma de Nuevo Leon . MX2013012355 (2015).
  • Universidad Nacional Autonoma de Mexico . MX2012014556 (2014).
  • Benemerita Universidad Autonoma de Puebla . MX2014001768 (2015).
  • Benemerita Universidad Autonoma de Puebla . MX2014001759 (2015).
  • Benemerita Universidad Autonoma de Puebla . MX2017015195 (2019).
  • Márquez-Domínguez L , Reyes-LeyvaJ , Herrera-CamachoIet al. Five novel non-sialic acid-like scaffolds inhibit in vitro H1N1 and H5N2 neuraminidase activity of influenza a virus. Molecules25(18), 4248 (2020).
  • Gong H , PengS. Effects of patent policy on innovation outputs and commercialization: evidence from universities in China. Scientometrics117(2), 687–703 (2018).
  • Giuri P , MunariF , ScanduraAet al. The strategic orientation of universities in knowledge transfer activities. Technol. Forecast Soc. Change138, 261–278 (2019).
  • Backs S , GüntherM , StummerC. Stimulating academic patenting in a university ecosystem: an agent-based simulation approach. J. Technol. Transf.44(2), 434–461 (2019).
  • Fischer BB , SchaefferPR , VonortasNS. Evolution of university-industry collaboration in Brazil from a technology upgrading perspective. Technol. Forecast Soc. Change145, 330–340 (2019).
  • Perez-Aleman P , FerrettiT. Creating innovation capabilities for improving global health: inventing technology for neglected tropical diseases in Brazil. J. Inter. Bus. Pol. doi: 10.1057/s42214-022-00143-y (2022) ( Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.